The Union - North America Region

End TB 2019: 23rd Annual Conference of The Union-North America Region

We look forward to welcoming you in Vancouver for the End TB 2019 Conference. Our multidisciplinary planning committee has been hard at work to bring you a robust and engaging program that will include timely topics such as advocacy and policymaker perspectives on the UN High-Level Meeting on TB, the latest on TB diagnostics, drugs, treatment, prevention and clinical trials, LTBI treatment for special populations such as the elderly and non-HIV immunosuppressed, and approaches to effective community engagement. 

Highlights will include keynote addresses from Dr. Patricia Daly on opioid use and TB and from Dr. Eric Goosby on the next steps following the UN High-Level Meeting on TB.

Download the conference brochure

Conference registration now open

Exhibitor and Sponsorship Opportunities

We offer a number of ways for our partners to become engaged with the 23rd Annual Conference of The Union-NAR. Showcase your products and services to delegates ranging from global health agencies, to talented new researchers in the field. For more information, contact Menn Biagtan at biagtan@bc.lung.ca. 

Exhibitor Registration


Call for Late-Breaking Abstracts

We encourage you to submit your recently completed research on all aspects of tuberculosis care and prevention, including epidemiologic, clinical, basic science, nursing, social, behavioural, psychosocial and educational studies, as well as outcomes of program initiatives. Selected abstracts will be eligible for poster presentation only. We regret we do not have additional travel grants at this time. 

Deadline: December 12, 2018

Abstract Submission Guideline

Submit Abstract Online


Lifetime Achievement Award and Service Award Nominations

The North American Region of The Union is calling for nominations of its awards. Each year, the region recognizes the valuable contributions of our colleagues working in the field of tuberculosis control and prevention. The awards will be presented during the 23rd Annual Conference of The Union-NAR, which will be held in Vancouver, Canada on February 21-23, 2019. Deadline for nominations for awards is October 9, 2018.

List of Previous Award Recipients

Service Awards are given to individuals who have made a significant contribution to the field of TB. Previous recipients have included administrators, educators, public health advisors, nurses, and physicians.

Nominate an individual for Service Award 

Lifetime Achievement Award is the highest honour of the region. It is given to an individual who has made outstanding contributions in the field of TB over a lifetime. 

Nominate an individual for Lifetime Achievement Award


Call for Nominations for President-Elect

The Union-North America Region is seeking nominations for President-Elect. The mission of NAR is to harness the significant capacity of the region to promote better lung health. In order to fulfill this mission, we need all our members, countries, groups and organizations to be actively involved. The unofficial practice of NAR has been to alternate its presidents between Canada and the U.S. 

In this call, we will be accepting nominations from Canada. It is important that the executive committee, on which the President-Elect sits, reflects the broad experience, skills, wisdom and capacity of our membership. Deadline for nomination is November 7, 2018.

The President-Elect will automatically become President of the Union-NAR after serving a term of two (2) years under the mentorship of the President and per NAR Charter. The President-Elect will also assist the Past-President in co-chairing the Nominating Committee.

Nominate an individual for President-Elect

 

 

2018 Meeting Archives

Click here to view the End TB 2018 Abstract Book

Stop TB Session

Progress and Challenges towards Ending TB in a Politically Charged Era
Dr. Mario Raviglione, Geneva, Switzerland

Implementation Science – Rationale and Application to TB Research in Low-Income Settings
Dr. Adithya Cattamanchi, University of California San Francisco, San Francisco, CA, USA

Programmatic Uptake of Novel Treatments for Multidrug-Resistant TB: A Failure of Innovation?
Dr. Jennifer Furin, Harvard University, Boston, MA, USA

Update from TB Alliance Clinical Studies
Dr. Daniel Everitt, TB Alliance, New York, NY, USA

 

George Comstock Lecture

Programmatic and Clinical Issues Arising from National Tuberculosis Prevalence Surveys: “All We Know About TB is Wrong”
Dr. Phil C. Hopewell, Francis Curry International TB Center, San Francisco, CA, USA

 

Nursing-Sponsored Session

Engaging TB Patients/Survivors to Support One Another and Educate Community Leaders and Decision Makers
Ms. Terasa Rugg and Ms. Liz Stapf, TB Photovoice, Seattle, WA, USA

Meeting Communication Challenges of TB Patients in Illinois
Ms. Elaine Darnall and Ms. Janette Candido, Illinois Department of Public Health, Chicago, IL, USA

A New Tool for the Toolbox: The Patient LTBI Treatment Decision Aid
Dr. John Parmer, Centers for Disease Control, Atlanta, GA, USA

Community Engagement among Inuit in Nunavut: Lessons from the Field
Dr. Gonzalo Alvarez, University of Ottawa, Ottawa, ON, Canada

Disseminating TB Control Messages to New Networks in North America and Around the World
Ms. Debra Daugherty, Stop TB USA, Washington, DC, USA

 

Whole Genome Sequencing and Drug Resistance

The Nix-TB Trial: Genotypic-Phenotypic DST Correlations and Identification of Reinfection in Trials
Dr. Daniel Everitt, TB Alliance, New York, NY, USA

Treatment of INH Resistant TB
Dr. Dick Menzies, McGill University, Montreal, QC, Canada

Use of Whole Genome Sequencing of Mycobacteria as a First Line Diagnostic Clinical Service in England
Prof. Tim Peto, University of Oxford, Oxford, UK

Using WGS to Drive TB Elimination in a Low-Incidence Setting
Dr. Jennifer Gardy, BC Centre for Disease Control, Vancouver, BC, Canada

 

Beyond TB Lecture

Climate Change and Human Health
Dr. Donald Wuebbles, University of Illinois, Urbana, IL, USA

 

Pediatric and Perinatal TB

TB and Infertility
Dr. Dina Fisher, Alberta Health Services, Calgary, AB, Canada

Diagnosing and Treating Tuberculosis in Pregnant Women: Current Practices and Research Opportunities
Dr. Jyoti Mathad, Center for Global Health/Weill Cornell University, New York, NY, USA

Comparison of the TST and IGRAs in Diagnosing Tuberculosis Infection and Predicting Progression to Tuberculosis Disease in Children
Dr. Amina Ahmed, Levine Children’s Hospital, Charlotte, NC, USA

The 2018 AAP Red Book: New Recommendations for Childhood Tuberculosis
Dr. Jeffrey R. Starke, Baylor College of Medicine, Houston, TX, USA

Current Status of Drugs Used in Treatment of MDR-TB in Children
Prof. Simon Schaaf, Stellenbosch University, Cape Town, South Africa

 

TB Elimination: Measurements and Outcomes

Latent TB Cascade of Care
Dr. Dick Menzies, McGill University, Montreal, QC, Canada

Dynamics of Tuberculosis in the United States: A Closer Look at Heterogeneity on the State Level
Dr. David Dowdy, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA

TB Elimination: Indicators in the United States
Dr. Pennan Barry, University of California San Francisco, San Francisco, CA, USA

Using the LTBI Cascade of Care in Public Health and Primary Care Clinics
Dr. Michelle Haas, Denver Public Health, Denver, CO, USA

 

Special Lecture

Developing a Human Rights-Based Approach to TB
Mr. Brian Citro, Northwestern Pritzker School of Law, Chicago, IL, USA

 

TB and Non-Communicable Diseases

Diabetic Immunopathy and TB
Dr. Hardy Kornfeld, University of Massachusetts Medical School, Worcester, MA, USA

TB and Smoking
Dr. Jonathan Golub, Johns Hopkins School of Medicine, Baltimore, MD, USA

TB and Alcohol Use
Dr. Karen Jacobson, Boston University School of Medicine, Boston, MA, USA


NAR Charter

Read the Charter of the North America Region of The Union.


Past Meeting Archives:

Page Last Updated: 23/10/2018